Personalised medicine in advanced breast cancer: AI-driven genomic test for CDK4/6 treatment response prediction
Speaker(s):
- Alicja Woźna, MSc, Adam Mickiewicz University
Human Papilloma Virus Integration Strictly Correlates with Global Genome Instability in Head and Neck Cancer
Speaker(s):
- David Goldrich, MD, Penn State Milton S. Hershey Medical Center
Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials
Speaker(s):
- Deborah Plana, BS, Harvard Medical School
Detecting Bacterial-Human Lateral Gene Transfer in Chronic Lymphocytic Leukemia
Speaker(s):
- Ekaterina Akimova, MSc, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR)
Synthetic lethality-mediated precision oncology via the tumor transcriptome
Speaker(s):
- Joo S. Lee, PhD, National Cancer Institute
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells in patients with soft tissue sarcoma
Speaker(s):
- Long-Sheng Lu, MD, PhD, Taipei Medical University
An unveiled Cell-Death Mechanism Exclusive to Human Cancer Cells
Speaker(s):
- Malka Armon, PhD, Tel-Aviv University
The development of a personalized CAM Avatar model to predict chemotherapeutic drug sensitivity/resistance of malignant glial tumors.
Speaker(s):
- Martine Charbonneau, MSc, Sherbrooke University
Clinical Feasibility and Treatment Outcomes With Unselected Autologous Tumor Infiltrating Lymphocyte Therapy in Patients With Advanced Cutaneous Melanoma
Speaker(s):
- Robert Hawkins, PhD, Instil Bio, Inc.
Unraveling the Molecular Determinants of Keloid Formation and Variable Effects of Steroid Treatment using Patient Derived Keloid Fibroblasts
Speaker(s):
- Yuna Son, MS, Florida State University